awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q54640859-D05F1E21-320F-4794-826C-374F68A05D29
Q54640859-D05F1E21-320F-4794-826C-374F68A05D29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54640859-D05F1E21-320F-4794-826C-374F68A05D29
The impact of tumor burden characteristics in patients with metastatic renal cell carcinoma treated with sunitinib.
P2860
Q54640859-D05F1E21-320F-4794-826C-374F68A05D29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54640859-D05F1E21-320F-4794-826C-374F68A05D29
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a551ea7f8e98fc0e04efae4ca33eedd26dbbde69
P2860
Bevacizumab reduces the growth rate constants of renal carcinomas: a novel algorithm suggests early discontinuation of bevacizumab resulted in a lack of survival advantage.